In a dramatic sequence of events that unfolded over just four days in early February 2026, online health and wellness company Hims & Hers launched, defended, and then abruptly withdrew a compounded version of Novo Nordisks newly approved Wegovy (semaglutide) pill for obesity
That's the distance between the pupil and the mouth divided by the distance between your pupils
This post explains the most common reasons people feel tired on semaglutide (the active ingredient in Ozempic and Wegovy) and other GLP-1 medicines, plus simple food-first fixes that usually help
In Arkansas, Blue Cross generated $2.9 billion in revenue but had a net loss of $226 million in 2024, and cited weight-loss drugs as one reason for higher costs
Testing notes a provider may consider
Whether the combination produces additive cardiovascular benefit beyond either approach alone remains to be studied definitively, but the mechanistic case is reasonable